R Ferrini

Author PubWeight™ 32.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998 4.78
2 Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 1998 3.37
3 Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998 2.92
4 Function of the TCR alpha enhancer in alphabeta and gammadelta T cells. Immunity 1997 2.51
5 1-Methyl-8-beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature 1965 2.00
6 American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med 1998 1.74
7 RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 1999 1.66
8 Class switching in B cells lacking 3' immunoglobulin heavy chain enhancers. J Exp Med 1998 1.58
9 Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J Exp Med 1999 1.38
10 Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 2001 1.24
11 SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 1998 1.22
12 Developmental regulation of TCR delta locus accessibility and expression by the TCR delta enhancer. Immunity 1999 1.13
13 Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA. Psychopharmacologia 1965 1.12
14 RAG2 is regulated differentially in B and T cells by elements 5' of the promoter. Proc Natl Acad Sci U S A 1999 0.97
15 Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class. Arzneimittelforschung 1974 0.96
16 Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists. Arzneimittelforschung 1986 0.79
17 Activity of ibopamine on some isolated organs. Arzneimittelforschung 1986 0.78
18 Effectiveness of erythrocytapheresis in idiopathic hemochromatosis. Report of 14 cases. Int J Artif Organs 1989 0.78
19 Cardiovascular and renal action of dopaminergic prodrugs. J Cardiovasc Pharmacol 1989 0.77
20 Effect of camazepam (SB-5833), a new antianxious drug, on cardiac contractility and coronary hemodynamics. Arzneimittelforschung 1974 0.76
21 The efficacy of mammography and screening for breast cancer. JAMA 1995 0.75
22 [Effect of glaziovine on exploratory activity of aggressive mice in the so-called "holey board" test]. Boll Soc Ital Biol Sper 1974 0.75
23 Activity of ibopamine on central nervous system in mice and rats. Arzneimittelforschung 1986 0.75
24 [Effects of ATP on myocardial metabolism in non-anesthetized dogs]. Boll Soc Ital Cardiol 1969 0.75
25 [Antagonists of adrenergic beta-receptors. 3. 1-aryloxy and 1-arylamino-3-amino-2-propanols]. Boll Chim Farm 1968 0.75
26 [Pharmacologic action of new derivatives chemically related to guanethidine]. Farmaco Sci 1965 0.75
27 Phosphatase activity of guinea-pig tissues on creatinol O-phosphate in vitro. J Pharm Pharmacol 1972 0.75
28 Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice. Arzneimittelforschung 1979 0.75
29 Synthesis and pharmacological evaluation of 6-(7-theophylline)-3(2H)-pyridazinone. Arch Pharm (Weinheim) 1991 0.75
30 [Effects of creatinol O-phosphate on the isolated rabbit's atrium and on the rat's phrenic nerve diaphragm preparation]. Farmaco Sci 1975 0.75
31 [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites]. Cardiologia 1988 0.75
32 Comparative evaluation of dopamine and other adrenergic amines in some isolated organs. Farmaco Prat 1972 0.75
33 [Adrenergic beta receptor blockaders. IV. 1-(Hydroxy- or dihydroxyphenoxy)-3-isopropylamino-2-propanols]. Boll Chim Farm 1973 0.75
34 [Inotropic and chronotropic effects of some benzodiazepines on the guinea-pig atrium]. Boll Soc Ital Biol Sper 1973 0.75
35 The qualities of the analyst. Am J Psychoanal 1996 0.75
36 Synthesis and pharmacological evaluation of respiratory stimulant amides of imidazo(1,2-a)pyridine-2,3-dicarboxylic acids. Farmaco Sci 1972 0.75
37 Synthesis and antiarrhythmic activity of 5,5-disubstituted-3-aminoalkylhydantions and some heterocyclic and noncyclic analogues. Farmaco Sci 1974 0.75
38 Some pharmacological properties of four stereoisomers of butidrine, a new adrenergic beta-receptor antagonist. Arzneimittelforschung 1968 0.75
39 [Antagonism of the effect of dopamine and norepinephrine on some isolated organs]. Boll Soc Ital Biol Sper 1973 0.75
40 Capillary protective and antiinflammatory activity of alpha,4-dihydroxy-3-methoxyacetophenone and some of its esters. Farmaco Sci 1968 0.75
41 Synthesis of compounds with a possible Ca-antagonist and beta-blocking activity. Arch Pharm (Weinheim) 1988 0.75
42 Effect of ibopamine on diuresis in conscious rats in normal and experimentally altered conditions. Arzneimittelforschung 1986 0.75
43 Derivatives of pyrrolo(2,1-a)isoquinoline. II. Monoamides of 5,6-dihydropyrrolo(2,1-a)isoquinoline-2,3-dicarboxylic acids. Farmaco Sci 1972 0.75
44 Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent. Arzneimittelforschung 1970 0.75
45 Synthesis of some isoindolines and 1,2,3,4-tetrahydroisoquinolines and their evaluation as alpha-adrenergic and adrenergic neuron blocking agents. Farmaco Sci 1972 0.75
46 [Effects of ATP on systemic hemodynamics of the anesthetized and un-anesthetized dog]. Boll Soc Ital Cardiol 1970 0.75
47 Increased barbiturate sleeping time by simultaneous administration of cardiac glycosides to mice. J Pharm Pharmacol 1967 0.75
48 Pharmacological actions of N-(2-o-methoxyphenoxyethyl)-6,7-dimethoxy-3,4-dihydro-2-(1H)-isoquinoline carboxamidine hydrobromide (SC-3123). Boll Chim Farm 1972 0.75
49 [Changes in choleresis in rats induced with some solvents and vehicles of drugs]. Boll Soc Ital Biol Sper 1973 0.75
50 Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum. Naunyn Schmiedebergs Arch Pharmacol 1990 0.75
51 [Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery]. Boll Soc Ital Biol Sper 1974 0.75
52 Synthesis and pharmacological evaluation of some pyrrolo[2,1-a]isoquinolines. J Med Chem 1968 0.75
53 [The effect of glaziovine on exploratory behavior of normal mice in the so-called "holey board" test]. Boll Soc Ital Biol Sper 1974 0.75
54 Neuroleptic phenothiazines with 1,4-diazabicyclo-[4.4.0]decane and-[4.3.0]nonane Ring System. Arzneimittelforschung 1971 0.75
55 [The pharmacological actions of butidrine. A comparative study of this new beta-adrenergic receptor antagonist and its four stereoisomers]. Arzneimittelforschung 1968 0.75
56 [Effect of G strophantin administered per os on the myocardial contractility in the anesthetized dog. Comparison with digoxin]. Boll Soc Ital Biol Sper 1972 0.75
57 Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo. Arzneimittelforschung 1979 0.75